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Orexin System and Avian Muscle 
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Kentu Lassiter and Sami Dridi
Abstract
In mammals, orexin A and B (also known as hypocretin 1 and 2) are two orexi-
genic peptides produced primarily by the lateral hypothalamus that signal through 
two G-protein-coupled receptors, orexin receptors 1/2, and have been implicated in 
the regulation of several physiological processes. However, the physiological roles of 
orexin are not well defined in avian (non-mammalian vertebrate) species. Recently, 
we made a breakthrough by identifying that orexin and its related receptors 1/2 
(ORXR1/2) are expressed in avian muscle tissue and cell line, and appears to be a 
secretory protein. Functional in vitro studies showed that orexin A and B differen-
tially regulated expression of the orexin system, suggesting that orexins might have 
autocrine, paracrine, and/or endocrine roles. Administration of recombinant orexin 
modulated mitochondrial biogenesis, dynamics, function, and bioenergetics. In 
this chapter, we include a brief overview of the (patho) physiological role of orexin, 
comparative findings between mammalian and avian orexin, and in-depth analysis 
of orexin’s action on avian muscle mitochondria.
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1. Introduction
Orexin/hypocretin was originally identified by two different groups and 
reported in 1998 as an orexigenic feeding-related neuropeptide mainly produced in 
the rat hypothalamus [1, 2]. Numerous subsequent studies conducted in mammals 
have shown that orexin and its receptors regulate several physiological processes 
including food and water intake [3], control of wakefulness [4], circadian clock 
[5], energy and glucose homeostasis [6–8], lipid metabolism [9, 10], heart rate and 
blood pressure [11, 12], and neuroendocrine response to stress [13]. Despite these 
advancements in understanding the orexin system, studies investigating its distri-
bution and function in avian (non-mammalian vertebrate) species are very limited 
and merit more consideration and further in-depth explorations. Understanding 
orexin distribution and unraveling its function in avian tissues, particularly in 
broiler (meat-type chickens) skeletal muscle is of particular importance not only to 
the poultry industry, but also to the biomedical field.
The poultry (meat and egg) industry supports the livelihoods and food security 
of billions of people worldwide with an average annual production of 118 million 
metric tons of meat and 1360 billion eggs in 2017 [14]. This success was mainly 
achieved by intensive genetic selection for important economic and agricultural 
traits such as high growth rate, improved feed efficiency (conversion of feed to 
muscle mass), and increased muscle mass [15]. Today, indeed, modern broilers are 
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marketed in about half the time and at about twice the body weight compared to 
50–60 years ago [16]. This fast growth is largely allocated to the beast muscle [17].
Chickens are naturally hyperglycemic compared with mammals [18], insulin-
resistant [19], lack the glucose transporter GLUT4 [20], lack functional brown 
adipose tissue [21], and are prone to obesity [22], and thereby they represent a 
highly relevant animal model for biomedical researches.
The proper function of mitochondria is invariably related to muscle growth 
since these organelles produce a vast majority (~90%) of the ATP needed for tissue 
growth and maintenance of energy metabolism homeostasis. Previous studies in 
broiler chickens have shown that mitochondrial perturbations are directly related 
to a decrease in feed efficiency. Additionally, the absence of orexin’s effect on feed 
intake in chickens [23] suggest that this neuropeptide may be more involved in 
other peripheral metabolic and physiological processes rather than food/water 
intake and wakefulness that is seen in mammals. Therefore, if orexin and its 
receptors are shown to be present in skeletal muscle tissue of avian species, they 
may be exerting control of energy metabolism and muscle growth (i.e., myogen-
esis, insulin sensitivity, and glucose transport) in the cell in part by regulating 
mitochondrial dynamics. The role of orexin in skeletal muscle function could be of 
interest not only in improving health and feed efficiency of agricultural animals, 
but also in molecular medicine for pathophysiological understanding and thera-
peutic perspectives.
2. Identification of orexin and its receptors
Orexin, which regulates wakefulness, energy homeostasis, and appetite/feed-
ing behavior based on nutritional status, is a neuropeptide that was originally 
discovered in the hypothalamus of rats by two different research groups in 1998. 
De Lecea’s group isolated cDNAs selectively expressed within the hypothalamus 
and found that two peptides showed high amino acid sequence homology with 
secretin (the gut peptide hormone), therefore they named the two peptides 
hypocretin 1 and 2 [1]. Sakurai’s group, on the other hand, used reverse phar-
macology to identify ligands of orphan G-protein-coupled receptors. Orphan 
receptors are those whose ligand and physiological actions are unknown [24]. 
They identified a novel family of neuropeptides that induced feeding behavior, so 
they named them orexin A and B [2]. The term orexin originates from the Greek 
word “orexis,” meaning appetite. Both orexin A and B are formed by proteolytic 
cleavage of the precursor prepro-orexin [2]. When initially discovered in rats, 
the precursor peptide prepro-orexin was shown to be a 130-residue polypeptide 
from which the mature peptides ORX-A and ORX-B were formed, with ORX-A 
containing 33 amino acids and a molecular weight 3.562 kDa and ORX-B contain-
ing 28 amino acids and a molecular weight of 2.937 kDa [2]. When comparing the 
two peptides, ORX-B was shown to be 56% identical in amino acid sequence to 
ORX-A. However, when comparing mammalian species (human, rat, mouse, pig, 
and cow), the sequence and structure of both peptides is highly conserved [2]. A 
number of studies have also shown that the structures of ORX-A and ORX-B in 
chicken and certain types of fish are conserved when compared to their mamma-
lian counterparts [25–28].
ORX-A and ORX-B signal through the G-protein-coupled receptors orexin 
receptor 1 (ORXR1) and orexin receptor 2 (ORXR2). These two ubiquitously 
expressed receptors were first identified in human brain tissue through expressed 
sequence tags combined with database searching using tBLASTn [2, 29]. In humans 
it has been shown that the amino acid sequence for ORXR1 and ORXR2 is more than 
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60% identical, making them more similar to each other than to other G-protein-
coupled receptors [2]. The same study also showed that both receptors are highly 
conserved between humans and rats, with the sequence identity being greater 
than 90% for both. The two orexin peptides have different binding affinities for 
the two orexin receptors. ORX-A is able to bind to both receptors but has a higher 
affinity for ORXR1, while ORX-B binds to ORXR2 with the same affinity as ORX-A 
[28]. Several studies have indicated that the binding of orexins to orexin receptors 
activates multiple G-proteins. In studies conducted using humans [30, 31] and rats 
[32], it was shown that the binding of ORXR2 activates Gi, Gs, Go, and Gq proteins 
in adrenal cortical tissue. It appears that the responses to orexin receptor signaling 
are highly diverse. The activation of the various G-proteins can lead to a variety of 
cellular responses such as the regulation of protein/lipid kinases [33, 34]. In the case 
of orexin stimulation, activation of G-proteins can lead to the excitation of neurons 
that affect the regulation of ion channels, the activation of signaling cascades that 
regulate the activity of adenylyl cyclase and phospholipases, and activation of cell 
death pathways [35, 36].
3. Orexin system in avian species
Significantly fewer studies concerning the orexin system have been conducted in 
avian species when compared to mammals. Chicken prepro-orexin was first cloned, 
sequenced, and characterized in 2002 [37]. In that study, chicken orexin cDNA was 
shown to be expressed in the periventricular and lateral hypothalamic areas and 
consisting of 658 bp that encode 148 amino acids. Also, chicken ORX-A and ORX-B 
are evolutionary conserved with their mammalian counterparts, showing ~85 and 
65% similarity at the amino acid level [37]. Characterization of the chicken orexin 
receptor shows that its cDNA has a length of 1869 bp that encode 501 amino acids, 
which corresponds to mammalian ORXR2 with an 80% homology [37]. Studies 
looking at tissue distribution of orexin and orexin receptors in chickens show that 
the peptides are expressed in the brain [37–40], pituitary gland, adrenal gland, 
testis and ovary [38], and the stomach and intestine [41].
Orexin does not appear to elicit the same responses in birds as it does in mam-
mals. One of the most noted actions that centrally administered orexin has in 
mammals is that it stimulates feeding/food intake [2, 3, 28, 42]. However, central 
administration of ORX-A or ORX-B did not stimulate feed intake in neonatal 
broiler and layer chicks [23, 43] or adult pigeons [44]. Studies examining mRNA 
expression of prepro-orexin in the hypothalamus of chicken [37] and quail [45] 
following 24 h fasting showed no increase in expression, providing further evi-
dence for the lack of a stimulatory effect on feeding behavior in birds. Another 
feeding behavior study did show an increase in prepro-orexin mRNA [46], but this 
was measured after 48 h fasting, which would be an extreme fasting condition for 
broiler chickens.
As stated previously, another hallmark of orexin function in mammals is its 
effects on the regulation of sleep/wakefulness, where a dysfunction in the orexin 
system is associated with the sleep condition narcolepsy [4]. Studies investigating 
the effects of orexin on arousal in birds have been conducted with mixed results. 
It has been concluded that either hypothalamic orexin does not play a role in 
arousal of the sleep/wake cycle [39], or that only ORX-A in conjunction with the 
enzyme monoamine oxidase-A (MAO-A) increases arousal in layer chicks only and 
not broiler chicks [43, 47]. Multiple studies investigating orexin in avian species 
theorize that the peptide appears to be more involved in the regulation of energy 
metabolism than feed intake and sleep/wake cycles [39, 40, 48].
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4. Orexin system in avian muscle
Studies investigating the orexin-producing neurons in the rat/mouse brain 
report that central administration of the neuropeptide facilitates changes in 
Figure 1. 
Prepro-orexin and its related receptors are expressed in broiler chicken muscle (a, b) and QM7 cell line 
(c–f). (a) RT-PCR. Total RNA (1 μg) was reverse transcribed and subjected to RT-PCR. Brain, testis, 
and ovary were used as positive controls. (b) Western blot. 70 μg total protein extracted from each tissue 
were electrophoresed and blotted onto polyvinylidene difluoride membrane. Prepro-orexin (ORX) and 
orexin receptor 1 (ORXR1) expression was detected by immunoblot using rabbit anti-mouse ORX and 
rabbit anti-rat ORXR1 antibodies. Hypothalamus and brain were used as positive controls. The figure is a 
representative picture from one animal. (c) RT-PCR. Total RNA (1 μg) was isolated from chicken brain 
and QM7 cells and subjected to RT-PCR. (d) Western blot. Total protein extracted from the cells were 
electrophoresed and blotted onto polyvinylidene difluoride membrane. Prepro-orexin (ORX) and ORXR1/2 
expression was detected by immunoblot using rabbit anti-mouse ORX and rabbit anti-rat ORXR1/2 
antibodies. Brain was used as positive control. (e) Northern blot. Total RNA (10 μg) was separated by 
agarose gel electrophoresis and transferred to a nylon membrane and hybridized with specific biotin-
labeled DNA probe toward chicken ORX, and 18S. Hybridization signals were detected by FluorChem M 
MultiFluor system. ( f) Immunofluorescence staining. Intracellular ORX system distribution visualized by 
fluorescent microscope in the presence of a secondary antibody conjugated with Alexa Fluor 488 (green) 
and DAPI (blue).
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skeletal muscle tone [49, 50] in addition to increasing glucose metabolism and 
insulin sensitivity of skeletal muscle [51]. This indicates that orexin signaling in 
the central nervous system regulates muscle glucose metabolism by activating 
muscle sympathetic nerves. Even though the orexin system has been identified 
in the peripheral tissues of a variety of vertebrate species [52], very few studies 
have been conducted to determine whether orexin and its related receptors are 
expressed in vertebrate skeletal muscle and if so, what effects it’s presence may 
have on vertebrate muscle function and physiology. Review of the current litera-
ture shows that to date orexin has only been identified as being expressed in 
the heart muscle of zebrafish [53] and skeletal muscle of goldfish, chicken, and 
quail [54–56].
We have conducted studies using RT-PCR and Western blot analysis to iden-
tify both orexin and its related receptors as being expressed in broiler chicken 
muscle (Figure 1a, b). In addition, RT-PCR, Western blot analysis, Northern 
blot analysis, and immunofluorescence have been used to illustrate that orexin 
and its receptors are also expressed in the cytoplasmic compartment of a spon-
taneously immortalized quail muscle (QM7) cell line (Figure 1c–f). In humans, 
scientific evidence indicates that orexin is a secretory peptide due to its presence 
in the blood circulation. Additional support for orexin being secreted is given 
by the first 33 amino acids of human prepro-orexin containing a hydrophobic 
core followed by residues with small polar side chains, which are characteristics 
of a secretory signal sequence [57]. Cell culture experiments using the QM7 cell 
line have been carried out in order to determine whether orexin is also secreted 
in avian muscle. When QM7 cells are incubated in serum-free growth media in 
the presence of recombinant human orexin B (rORX-B), an increase in the level 
of prepro-orexin in the growth media is evident as seen in Figure 2a. Further 
support for the secretion of prepro-orexin is illustrated in Figure 2b where the 
levels of prepro-orexin in the serum-free growth media accumulate over a 72 h 
period, and in Figure 2c where application of the anti-secretory compound 
brefeldin A causes a buildup of prepro-orexin in the QM7 cell lysate and the 
subsequent absence of the peptide in the growth media. The expression and 
secretion of prepro-orexin from avian muscle cells suggests that avian orexin 
could be a myokine that probably functions in autocrine, paracrine, and/or 
endocrine roles.
Subsequent experiments were conducted in order to determine whether the 
orexin system is capable of self-regulation. The effects of 10 and 100 nM of 
recombinant human orexin A (rORX-A) and rORX-B on mRNA and protein 
expression of ORX and its related receptors ORXR1 and ORXR2 in QM7 cells are 
shown in Figure 2d–g. A 24 h treatment with either 10 or 100 nM rORX-A upreg-
ulated ORX and ORXR1, but not ORXR2 mRNA expression (Figure 2f). Treating 
cells with rORX-B downregulated ORX and ORXR2 and increased ORXR1 mRNA 
levels (Figure 2g). Protein expression levels of ORX, ORXR1, and ORXR2 showed 
the same patterns as their corresponding genes (Figure 2d, e) with the effects 
on expression levels appearing to be dose-dependent. The ability of rORX-A 
and rORX-B to differentially regulate gene and protein expression of the orexin 
system supports the idea that orexins function in an autocrine, paracrine, and/or 
endocrine role in avian muscle. Although the underlying mechanisms behind the 
differential regulation of the orexin system is still unknown, the divergent effects 
of rORX-A and rORX-B on orexin system expression might be related to their 
structure (presence of disulfide bonds in orexin A and not in orexin B) and their 
different binding affinity to ORXR2, since they had similar effects on ORXR1 
expression.
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4.1  The orexin system differentially regulates mitochondrial-related genes and 
mitochondrial bioenergetics in avian muscle cells
In mammals, orexin has been shown to induce differentiation of brown adipose 
tissue (BAT), subsequently leading to thermogenesis [58, 59]. One of the effects orexin 
has in this process is the regulation of genes involved in mitochondrial biogenesis. 
The treatment of mouse preadipocytes with ORX-A revealed a number of changes in 
Figure 2. 
Secretion of orexin by QM7 cells (a–c) and effect of orexin treatment on orexin system expression in QM7 
cells (d–g). (a) Cell monolayers were incubated in serum-free medium with rORX-B (100 nM) for up to 72 h 
prior to Western blotting. (b) Percent change in ORX levels when compared to control (2 h post-treatment). 
(c) Cells were incubated in serum-free medium with or without brefeldin A (0.3 μg/ml) for 12 h. Medium 
and/or cell lysates were subjected to immunoblot analysis using an orexin antibody. (d–g) Cells were treated 
with 0 (control), 10, or 100 nM of recombinant orexin A and B for 24 h. Total protein and RNA were isolated 
and relative expression of ORX and ORXR1/2 was determined. Protein levels were measured by Western blot 
analysis (d, e). mRNA expression was measured by QPCR using 2−ΔΔCt method (f, g). Data are expressed as 
means ± SE (n = 6). *Significant difference between orexin-treated and control cells (P < 0.05).
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mitochondrial dynamics, including up-regulation of the expression of a number of 
genes involved in mitochondrial biogenesis (i.e., PGC-1α, PGC-1β, PPARγ1, and UCP1) 
[58]. These findings were further supported when subsequent immunofluorescence 
staining revealed an increase in mitochondrial abundance of the treated cells. Studies 
using other cell types treated with ORX-A have also shown effects on mitochondrial 
function. Human neuroblastoma cells treated with ORX-A had increased mitochondrial 
membrane potential [60]. Additionally, in studies using human hepatoma cells [61] and 
human embryonic kidney cells [62], treatment with ORX-A resulted in increased ATP 
production that shifted from glycolysis in the cytoplasm to oxidative phosphorylation in 
the mitochondria. Taken together, these studies indicate that orexin is able to enhance 
mitochondrial function, biogenesis, and ATP production in mammalian vertebrates.
Similar experiments were carried out by treating QM7 cells with recombinant 
human orexin, as previously described, in order to observe the differential effects 
on mitochondrial-related genes, transcriptional regulators, and bioenergetics. 
Figure 3 illustrates how orexin causes differential expression of mitochondrial 
genes. rORX-A had no effect on av-UCP mRNA abundance (Figure 3b), but it 
downregulated the expression of av-ANT (mRNA and protein levels), Ski, and 
NRF-1 in a dose-dependent manner (Figure 3a, c, d). rORX-B, however, down-
regulated the expression of av-UCP and increased the expression of Ski and NRF-1 
without altering the expression of av-ANT (Figure 3a–d). The mitochondrial 
transcriptional regulators related to these genes were also differentially regulated 
following treatment with recombinant orexins as seen in Figure 3e–h. Both doses 
of rORX-A caused a significant downregulation of PPARδ and FoxO-1 expression 
(Figure 3g, h). A high dose of rORX-A significantly downregulated the expression 
of PGC-1β, and both doses did not alter PGC-1α mRNA abundance (Figure 3e, f). 
rORX-B, however, induced the expression of these transcription factors in a dose-
dependent manner, but the effects were statistically significant only for PGC-1α, 
PGC-1β, and FoxO-1 with the high dose (Figure 3e, f, h).
Since mitochondria are the powerhouse of the cell with central importance for 
producing more than 90% of the ATP needed to carry out essential cellular functions, 
these organelles are important for proper growth and development of skeletal muscle 
tissue. The changes in expression of mitochondrial-related genes and their transcrip-
tional regulators suggest that orexin may control mitochondrial respiratory function 
in avian muscle. To gain better insight into the physiological roles of orexins in avian 
muscle, mitochondrial bioenergetics in QM7 cells treated with 10 and 100 nM of 
rORX-A and rORX-B were assessed by monitoring basal oxygen consumption rate 
(OCR) followed by sequential treatment of cells with oligomycin, FCCP (carbonyl 
cyanide-4-phenylhydrazone), and antimycin A as shown in Figure 4f. As described 
previously [63], the decrease in OCR following oligomycin (which blocks ATP 
synthase) reveals OCR attributed to ATP synthesis activity. Maximal OCR is revealed 
in response to the uncoupling compound FCCP, and the difference between maximal 
OCR and basal OCR (prior to oligomycin) represents mitochondrial oxygen reserve 
capacity that cells can draw upon when increased energy production is needed. 
Oxygen consumption that remains following treatment with the electron transport 
inhibitor antimycin A is attributed to non-mitochondrial OCR (i.e., OCR due to activ-
ities other than non-mitochondrial c oxidase activity, such as mitochondrial reactive 
oxygen species production, oxidase activities, etc.). The amount of OCR attributed 
to proton leak is determined by the difference between oligomycin and antimycin 
A-inhibited OCR. When the non-mitochondrial component of cellular OCR was sub-
tracted and by setting maximal OCR following FCCP at 100%, the effects of ORX-A 
and ORX-B on ATP synthesis, reserve capacity, and proton leak were determined. 
ATP synthesis was slightly elevated by both orexins, but the effect was not statistically 
discernable. Analysis of reserve capacity indicated no effect of both doses of rORX-A 
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and rORX-B; however, proton leak was significantly decreased by 10 nM of rORX-A, 
and by 100 nM of rORX-B (Figure 4g). The combined data from these experiments 
illustrate that orexins lead to the alteration of mitochondrial-related genes, their tran-
scriptional regulators, and respiratory function in avian muscle cells. These changes 
suggest that orexin might also control mitochondrial dynamics (i.e., fusion/fission of 
mitochondria) in avian muscle.
Figure 3. 
Effect of orexin treatment on mitochondrial-related genes (a–d) and mitochondrial-transcriptional regulators 
(e–h) in QM7 cells. Cells were treated with recombinant orexin A or B (10 and 100 nM) for 24 h and the 
relative abundance of avian (av)-adenosine nucleotide translocator (ANT; a), UCP (b), Ski (c), nuclear 
respiratory factor 1 (NRF-1; d), PGC-1α (e), PGC-1β ( f), peroxisome proliferator-activated receptor δ 
(PPARδ; g), and FoxO-1 (h) were determined by QPCR. Untreated cells were used as control. Protein levels 
of av-ANT and PGC-1α were measured by Western blot analysis. Data are expressed as means ± SE (n = 6). 
*Significant difference between orexin-treated and control cells (P < 0.05).
9Orexin System and Avian Muscle Mitochondria
DOI: http://dx.doi.org/10.5772/intechopen.85177
4.2  Orexins differentially regulate mitochondrial biogenesis and dynamics in 
avian muscle cells
Since mtDNA replication and quantitation are a necessary component of 
mitochondrial biogenesis, the expression of mtDNA and mtSSBP1 was measured 
in orexin-treated QM7 cells as shown in Figure 4b, c. In contrast to rORX-A, in 
which both doses significantly downregulated mtDNA and upregulated mtSSBP1 
expression, rORX-B (high dose) significantly increased mtDNA expression without 
Figure 4. 
Effect of orexin treatment on mitochondrial distribution (a), mitochondrial DNA and mass (b–e), and 
mitochondrial bioenergetics (f, g) in QM7 cells. a: Cells were cultured in chamber slides and treated with 
100 nM of rORX-A or rORX-B for 24 h. Mitochondria were visualized with MitoTracker Red CMX Ros 
(75 nM) under a fluorescent microscope. Representative images acquired and deconvoluted are shown. (b–e) 
QM7 cells were treated with orexins (10 and 100 nM) for 24 h. The levels of mtDNA (b) and the relative 
expression of mtSSBP1 (c), mitochondrial markers CoxIV (d), and Cox5a (e) were determined by real-time 
PCR. (f, g) Oxygen consumption rate (OCR) (f) and the percentage of OCR due to proton leak (g) was 
determined using an XF24 flux Analyzer (Agilent Technologies). The values represent the means ±SE (n = 6). 
*Significant difference between orexin-treated and control cells (P < 0.05).
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affecting mtSSBP1 levels. Consistent with these observations and in contrast to 
rORX-A, rORX-B increased mitochondrial content as visualized with MitoTracker 
Red probe staining (Figure 4a). Neither rORX-A nor rORX-B affected the expres-
sion of the mitochondrial transcription factor TFAM (data not shown). The expres-
sion of Cox IV and Cox 5a genes, commonly used markers for mitochondrial mass 
Figure 5. 
Effect of orexin treatment on mitochondrial dynamics-related genes in QM7 cells. QM7 cells were treated 
with orexins (10 and 100 nM) for 24 h. The relative expression of four genes involved in mitochondrial fusion, 
MFN1 (a), MFN2 (b), OPA1 (c), OMA1 (d) and three genes involved in mitochondrial fission, MTFP1 (f), 
DNM1 (g), and MTFR1 (h) was determined by real-time PCR. The protein levels of MFN1, MFN2, and 
OPA1 were determined by Western blot analysis (e). The values represent the means ±SE (n = 6). *Significant 
difference between orexin-treated and control cells (P < 0.05).
11
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and biogenesis, was determined. The high dose (100 nM) of rORX-A decreased Cox 
IV gene expression; however, the high-dose of rORX-B significantly increased Cox 
IV and Cox 5a mRNA levels compared with untreated cells (Figure 4d, e).
Mitochondria are dynamic organelles in the cell that constantly fuse and divide, 
forming constantly changing tubular networks, according to the needs of the 
organism, thus leading to alterations in their morphology and function [64]. Since 
orexin is shown to alter expression of mitochondrial-related genes and transcrip-
tional regulators, it may also control avian muscle mitochondrial dynamics.  
The molecular mechanisms that control mitochondrial dynamics are complex 
and require participation and coordination of both the nuclear and mitochondrial 
genomes. In mammals this network has been partially unraveled after the iden-
tification of some of the genes responsible for mitochondrial fusion [mitofusins 
(MFN1 and MFN2), and optic atrophy 1 (OPA1)] and fission [dyanamin-related 
protein 1 (Drp1 or DNM1), fission 1 (FIS1), and mitochondrial protein 18 kDa]. Up 
until the current study, the integration of such a mitochondrial network is unknown 
in avian species. Following orexin treatment, the expression of four genes related to 
mitochondrial fusion and three genes related to mitochondrial fission were mea-
sured as shown in Figure 5. Recombinant ORX-B at high dose significantly induced 
the expression of MFN2, OPA1, and OMA1, but decreased the mRNA levels of 
MFN1 (Figure 5a–d). The same effect was observed at the protein levels (Figure 5e). 
However, rORX-A significantly downregulated the expression of MFN1 and OMA1 
with both doses, and OPA1 with the high dose, but did not affect that of MFN2 
(Figure 5a–d). Interestingly, and in contrast to rORX-B, where no significant 
effects were observed, rORX-A upregulated the expression of mitofission-related 
genes MTFP1, DNM1, and MTFR1 (Figure 5f–h). These orexin-induced changes 
in the expression of dynamics-related genes may serve in regulating mitochondrial 
metabolism in muscle cells in response to the needs of the animal during stages of 
growth and development.
5. Conclusions
Orexins are originally identified as hypothalamic neuropeptides that have potent 
orexigenic effects on appetite and feeding behavior in mammals. In avian species, 
however, orexins seem to be myokines that regulate the expression of their own 
system as well as muscle mitochondrial function, biogenesis, bioenergetics, and 
dynamics. As intensive genetic selection for fast growth rate, driven by human 
nutritional needs and economic demands, have resulted in dramatic increase in 
chicken body weight arising mainly from increased muscle mass, these finding open 
new vistas on the role of orexin system in muscle development and energy metabo-
lism. Further in depth investigations are warranted to understand the relationship 
between orexin system, mitochondrial network, and muscle growth and develop-
ment which, in turn, will be beneficial to the poultry industry as it has the potential 
to lead to increased production efficiency and reduced economic costs.
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